These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15109605)

  • 1. The androgen receptor ligand-binding domain stabilizes DNA binding in living cells.
    Farla P; Hersmus R; Geverts B; Mari PO; Nigg AL; Dubbink HJ; Trapman J; Houtsmuller AB
    J Struct Biol; 2004 Jul; 147(1):50-61. PubMed ID: 15109605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiandrogens prevent stable DNA-binding of the androgen receptor.
    Farla P; Hersmus R; Trapman J; Houtsmuller AB
    J Cell Sci; 2005 Sep; 118(Pt 18):4187-98. PubMed ID: 16141232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantifying effects of ligands on androgen receptor nuclear translocation, intranuclear dynamics, and solubility.
    Marcelli M; Stenoien DL; Szafran AT; Simeoni S; Agoulnik IU; Weigel NL; Moran T; Mikic I; Price JH; Mancini MA
    J Cell Biochem; 2006 Jul; 98(4):770-88. PubMed ID: 16440331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor.
    Doesburg P; Kuil CW; Berrevoets CA; Steketee K; Faber PW; Mulder E; Brinkmann AO; Trapman J
    Biochemistry; 1997 Feb; 36(5):1052-64. PubMed ID: 9033395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compartmentalization of androgen receptor protein-protein interactions in living cells.
    van Royen ME; Cunha SM; Brink MC; Mattern KA; Nigg AL; Dubbink HJ; Verschure PJ; Trapman J; Houtsmuller AB
    J Cell Biol; 2007 Apr; 177(1):63-72. PubMed ID: 17420290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired helix 12 dynamics due to proline 892 substitutions in the androgen receptor are associated with complete androgen insensitivity.
    Elhaji YA; Stoica I; Dennis S; Purisima EO; Lumbroso R; Beitel LK; Trifiro MA
    Hum Mol Genet; 2006 Mar; 15(6):921-31. PubMed ID: 16449235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mutation F826L in the human androgen receptor in partial androgen insensitivity syndrome; increased NH2-/COOH-terminal domain interaction and TIF2 co-activation.
    Wong HY; Hoogerbrugge JW; Pang KL; van Leeuwen M; van Royen ME; Molier M; Berrevoets CA; Dooijes D; Dubbink HJ; van de Wijngaart DJ; Wolffenbuttel KP; Trapman J; Kleijer WJ; Drop SL; Grootegoed JA; Brinkmann AO
    Mol Cell Endocrinol; 2008 Sep; 292(1-2):69-78. PubMed ID: 18656523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A differential ligand-mediated response of green fluorescent protein-tagged androgen receptor in living prostate cancer and non-prostate cancer cell lines.
    Nakauchi H; Matsuda K; Ochiai I; Kawauchi A; Mizutani Y; Miki T; Kawata M
    J Histochem Cytochem; 2007 Jun; 55(6):535-44. PubMed ID: 17312014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that lack of ligand-binding domain correlates with nuclear distribution of unliganded human androgen receptor and loss of transactivation activity.
    Suzuki N; Imai A
    Gynecol Endocrinol; 2011 Nov; 27(11):940-3. PubMed ID: 21501000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of targeting and intracellular trafficking of an anti-androgen doxorubicin-formaldehyde conjugate in PC-3 prostate cancer cells bearing androgen receptor-GFP chimera.
    Cogan PS; Koch TH
    J Med Chem; 2004 Nov; 47(23):5690-9. PubMed ID: 15509168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods to study dynamic interaction of androgen receptor with chromatin in living cells.
    Kirli HZ; Saatcioglu F
    Methods Mol Biol; 2011; 776():131-45. PubMed ID: 21796525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FRAP and FRET methods to study nuclear receptors in living cells.
    van Royen ME; Dinant C; Farla P; Trapman J; Houtsmuller AB
    Methods Mol Biol; 2009; 505():69-96. PubMed ID: 19117140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-domain communication between the N-terminal and DNA-binding domains of the androgen receptor: modulation of androgen response element DNA binding.
    Brodie J; McEwan IJ
    J Mol Endocrinol; 2005 Jun; 34(3):603-15. PubMed ID: 15956332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptor level controlled by a suppressor complex lost in an androgen-independent prostate cancer cell line.
    Wang LG; Ossowski L; Ferrari AC
    Oncogene; 2004 Jul; 23(30):5175-84. PubMed ID: 15156193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective role of an NH2-terminal WxxLF motif for aberrant androgen receptor activation in androgen depletion independent prostate cancer cells.
    Dehm SM; Regan KM; Schmidt LJ; Tindall DJ
    Cancer Res; 2007 Oct; 67(20):10067-77. PubMed ID: 17942941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probasin promoter assembles into a strongly positioned nucleosome that permits androgen receptor binding.
    Maffey AH; Ishibashi T; He C; Wang X; White AR; Hendy SC; Nelson CC; Rennie PS; Ausió J
    Mol Cell Endocrinol; 2007 Mar; 268(1-2):10-9. PubMed ID: 17316977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hinge region regulates DNA binding, nuclear translocation, and transactivation of the androgen receptor.
    Haelens A; Tanner T; Denayer S; Callewaert L; Claessens F
    Cancer Res; 2007 May; 67(9):4514-23. PubMed ID: 17483368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
    Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
    J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay.
    Ozers MS; Marks BD; Gowda K; Kupcho KR; Ervin KM; De Rosier T; Qadir N; Eliason HC; Riddle SM; Shekhani MS
    Biochemistry; 2007 Jan; 46(3):683-95. PubMed ID: 17223690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.